Journal
CASE REPORTS IN OPHTHALMOLOGY
Volume 3, Issue 1, Pages 123-127Publisher
KARGER
DOI: 10.1159/000337481
Keywords
Coats' disease; Retinal telangiectasis; Retinal vasoproliferative tumor; Dexamethasone intravitreal implant (Ozurdex (R))
Categories
Ask authors/readers for more resources
Purpose: To report a case of Coats' disease managed with the dexamethasone intravitreal implant Ozurdex (R) (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation. Methods: A 46-year-old female with 20/200 visual acuity was diagnosed with Coats' disease with secondary retinal vasoproliferative tumor. An initial approach was performed with an intravitreal injection of the sustained-release dexamethasone implant Ozurdex. After reattachment of the retina, the telangiectatic vessels were treated with laser photocoagulation. Results: The patient's visual acuity improved to 20/25 after the intravitreal Ozurdex. No further recurrences of exudation were evident through the 12-month follow-up. Conclusions: Ozurdex may be an effective initial therapeutic approach for Coats' disease with immediate anatomical response and visual improvement.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available